Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients
Kristina Schee(Oslo University Hospital), Elisabeth Paus(Oslo University Hospital), Kjersti Flatmark(Oslo University Hospital), Ruth Holm(University of Aleppo), Kjetil Boye(Oslo University Hospital)
Cited by 4
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome.
|PubMed|1993|589
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2021|558